Condensed Consolidated Statements of Stockholders’ Equity (unaudited) - USD ($)
$ in Thousands |
Total |
Issuance of shares of common stock sold under the ATM program, net of expenses |
Issuance of shares of common stock and pre-funded warrants from private placement financing |
Series A Warrants
2025 Private Placement
|
Series A Convertible Preferred Stock
Series A Convertible Preferred Stock
|
Common Stock |
Common Stock
Issuance of shares of common stock sold under the ATM program, net of expenses
|
Common Stock
Issuance of shares of common stock and pre-funded warrants from private placement financing
|
Common Stock
Series A Warrants
2025 Private Placement
|
Additional Paid-In Capital |
Additional Paid-In Capital
Issuance of shares of common stock sold under the ATM program, net of expenses
|
Additional Paid-In Capital
Issuance of shares of common stock and pre-funded warrants from private placement financing
|
Additional Paid-In Capital
Series A Warrants
2025 Private Placement
|
Accumulated Other Comprehensive Loss |
Accumulated Deficit |
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
|
|
1,250
|
|
|
|
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
$ 68,226
|
|
|
|
$ 0
|
$ 71
|
|
|
|
$ 372,489
|
|
|
|
$ (35)
|
$ (304,299)
|
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
|
|
|
71,009,866
|
|
|
|
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of shares of common stock from exercise of stock options, employee stock purchase plan and vesting of RSU awards (in shares) |
|
|
|
|
|
99,648
|
|
|
|
|
|
|
|
|
|
| Issuance of shares of common stock from exercise of stock options, employee stock purchase plan and vesting of RSU awards |
13
|
|
|
|
|
|
|
|
|
13
|
|
|
|
|
|
| Stock-based compensation expense |
1,284
|
|
|
|
|
|
|
|
|
1,284
|
|
|
|
|
|
| Other comprehensive loss |
(12)
|
|
|
|
|
|
|
|
|
|
|
|
|
(12)
|
|
| Net loss |
(10,235)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(10,235)
|
| Ending balance (in shares) at Mar. 31, 2025 |
|
|
|
|
1,250
|
|
|
|
|
|
|
|
|
|
|
| Ending balance at Mar. 31, 2025 |
59,276
|
|
|
|
$ 0
|
$ 71
|
|
|
|
373,786
|
|
|
|
(47)
|
(314,534)
|
| Ending balance (in shares) at Mar. 31, 2025 |
|
|
|
|
|
71,109,514
|
|
|
|
|
|
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
|
|
1,250
|
|
|
|
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
68,226
|
|
|
|
$ 0
|
$ 71
|
|
|
|
372,489
|
|
|
|
(35)
|
(304,299)
|
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
|
|
|
71,009,866
|
|
|
|
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
(14,919)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
|
|
1,250
|
|
|
|
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
55,789
|
|
|
|
$ 0
|
$ 71
|
|
|
|
375,005
|
|
|
|
(69)
|
(319,218)
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
|
|
|
71,109,514
|
|
|
|
|
|
|
|
|
|
| Beginning balance (in shares) at Mar. 31, 2025 |
|
|
|
|
1,250
|
|
|
|
|
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2025 |
59,276
|
|
|
|
$ 0
|
$ 71
|
|
|
|
373,786
|
|
|
|
(47)
|
(314,534)
|
| Beginning balance (in shares) at Mar. 31, 2025 |
|
|
|
|
|
71,109,514
|
|
|
|
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock-based compensation expense |
1,219
|
|
|
|
|
|
|
|
|
1,219
|
|
|
|
|
|
| Other comprehensive loss |
(22)
|
|
|
|
|
|
|
|
|
|
|
|
|
(22)
|
|
| Net loss |
(4,684)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4,684)
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
|
|
1,250
|
|
|
|
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
55,789
|
|
|
|
$ 0
|
$ 71
|
|
|
|
375,005
|
|
|
|
(69)
|
(319,218)
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
|
|
|
71,109,514
|
|
|
|
|
|
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2025 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2025 |
$ 130,660
|
|
|
|
$ 0
|
$ 130
|
|
|
|
452,445
|
|
|
|
(202)
|
(321,713)
|
| Beginning balance (in shares) at Dec. 31, 2025 |
130,184,353
|
|
|
|
|
130,184,353
|
|
|
|
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of shares of common stock sold under the ATM program, net of expenses (in shares) |
|
|
|
|
|
|
1,500,000
|
|
|
|
|
|
|
|
|
| Issuance of shares of common stock sold under the ATM program, net of expenses |
|
$ 2,367
|
|
|
|
|
$ 2
|
|
|
|
$ 2,365
|
|
|
|
|
| Issuance of shares of common stock and pre-funded warrants from private placement financing (in shares) |
|
|
|
|
|
|
|
19,154,321
|
|
|
|
|
|
|
|
| Issuance of shares of common stock and pre-funded warrants from private placement financing |
|
|
$ 60,000
|
|
|
|
|
$ 19
|
|
|
|
$ 59,981
|
|
|
|
| Expenses related to the issuance of shares of common stock and pre-funded warrants |
|
|
$ (3,816)
|
$ (1,593)
|
|
|
|
|
|
|
|
$ (3,816)
|
$ (1,593)
|
|
|
| Exercise of Series A warrants to shares of common stock and pre-funded warrants (in shares) |
|
|
|
|
|
|
|
|
16,140,663
|
|
|
|
|
|
|
| Exercise of Series A warrants to shares of common stock and pre-funded warrants |
|
|
|
26,593
|
|
|
|
|
$ 16
|
|
|
|
26,577
|
|
|
| Issuance of shares of common stock from exercise of stock options, employee stock purchase plan and vesting of RSU awards (in shares) |
|
|
|
|
|
287,129
|
|
|
|
|
|
|
|
|
|
| Issuance of shares of common stock from exercise of stock options, employee stock purchase plan and vesting of RSU awards |
$ 220
|
|
|
|
|
|
|
|
|
220
|
|
|
|
|
|
| Stock-based compensation expense |
1,046
|
|
|
|
|
|
|
|
|
1,046
|
|
|
|
|
|
| Other comprehensive loss |
(220)
|
|
|
|
|
|
|
|
|
|
|
|
|
(220)
|
|
| Net loss |
(16,988)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(16,988)
|
| Ending balance (in shares) at Mar. 31, 2026 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
| Ending balance at Mar. 31, 2026 |
198,269
|
|
|
|
$ 0
|
$ 167
|
|
|
|
537,225
|
|
|
|
(422)
|
(338,701)
|
| Ending balance (in shares) at Mar. 31, 2026 |
|
|
|
|
|
167,266,466
|
|
|
|
|
|
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2025 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2025 |
$ 130,660
|
|
|
|
$ 0
|
$ 130
|
|
|
|
452,445
|
|
|
|
(202)
|
(321,713)
|
| Beginning balance (in shares) at Dec. 31, 2025 |
130,184,353
|
|
|
|
|
130,184,353
|
|
|
|
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
$ (31,996)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2026 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2026 |
$ 209,890
|
|
|
|
$ 0
|
$ 185
|
|
|
|
564,165
|
|
|
|
(750)
|
(353,710)
|
| Ending balance (in shares) at Jun. 30, 2026 |
184,755,735
|
|
|
|
|
184,755,735
|
|
|
|
|
|
|
|
|
|
| Beginning balance (in shares) at Mar. 31, 2026 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2026 |
$ 198,269
|
|
|
|
$ 0
|
$ 167
|
|
|
|
537,225
|
|
|
|
(422)
|
(338,701)
|
| Beginning balance (in shares) at Mar. 31, 2026 |
|
|
|
|
|
167,266,466
|
|
|
|
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expenses related to the issuance of shares of common stock and pre-funded warrants |
|
|
|
(1,774)
|
|
|
|
|
|
|
|
|
(1,774)
|
|
|
| Exercise of Series A warrants to shares of common stock and pre-funded warrants (in shares) |
|
|
|
|
|
|
|
|
17,457,197
|
|
|
|
|
|
|
| Exercise of Series A warrants to shares of common stock and pre-funded warrants |
|
|
|
$ 27,294
|
|
|
|
|
$ 18
|
|
|
|
$ 27,276
|
|
|
| Issuance of shares of common stock from exercise of stock options, employee stock purchase plan and vesting of RSU awards (in shares) |
|
|
|
|
|
32,072
|
|
|
|
|
|
|
|
|
|
| Issuance of shares of common stock from exercise of stock options, employee stock purchase plan and vesting of RSU awards |
7
|
|
|
|
|
|
|
|
|
7
|
|
|
|
|
|
| Stock-based compensation expense |
1,431
|
|
|
|
|
|
|
|
|
1,431
|
|
|
|
|
|
| Other comprehensive loss |
(328)
|
|
|
|
|
|
|
|
|
|
|
|
|
(328)
|
|
| Net loss |
(15,009)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15,009)
|
| Ending balance (in shares) at Jun. 30, 2026 |
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2026 |
$ 209,890
|
|
|
|
$ 0
|
$ 185
|
|
|
|
$ 564,165
|
|
|
|
$ (750)
|
$ (353,710)
|
| Ending balance (in shares) at Jun. 30, 2026 |
184,755,735
|
|
|
|
|
184,755,735
|
|
|
|
|
|
|
|
|
|